✨ Medicine Consents




NEW ZEALAND GAZETTE, No. 70

21 APRIL 2005

1680

Product:
Concerta Extended Release Tablets

Active Ingredient:
Methylphenidate hydrochloride 54mg

Dosage Form:
Modified release tablet

New Zealand Sponsor:
Janssen-Cilag Pty Limited

Manufacturers:
Alza Corporation, Mountain View, California, United States of America
Alza Corporation, Vacaville, California, United States of America

Product:
Efexor-XR

Active Ingredient:
Venlafaxine hydrochloride 169.7mg equivalent to 150mg venlafaxine

Dosage Form:
Modified release capsule

New Zealand Sponsor:
Wyeth (NZ) Limited

Manufacturer:
Wyeth Pharmaceuticals Company, Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico

Product:
Efexor-XR

Active Ingredient:
Venlafaxine hydrochloride 84.85mg equivalent to 75mg venlafaxine

Dosage Form:
Modified release capsule

New Zealand Sponsor:
Wyeth (NZ) Limited

Manufacturer:
Wyeth Pharmaceuticals Company, Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico

Product:
Fragmin

Active Ingredient:
Dalteparin sodium 10,000IU/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturer:
Recip AB, Stockholm, Sweden

Product:
Fragmin

Active Ingredient:
Dalteparin sodium 12,500IU/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturer:
Recip AB, Stockholm, Sweden

Product:
Fragmin

Active Ingredient:
Dalteparin sodium 25,000IU/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Pfizer New Zealand Limited

Manufacturer:
Recip AB, Stockholm, Sweden

Product:
Pegasys

Active Ingredient:
Peginterferon alfa-2a 270Β΅g/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Manufacturer:
F Hoffmann-La Roche Ltd, Basel, Switzerland

Product:
Pegasys

Active Ingredient:
Peginterferon alfa-2a 360Β΅g/mL

Dosage Form:
Solution for injection

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Manufacturer:
F Hoffmann-La Roche Ltd, Basel, Switzerland

Product:
Xeloda

Active Ingredient:
Capecitabine 150mg

Dosage Form:
Film-coated tablet

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Manufacturers:
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom

Product:
Xeloda

Active Ingredient:
Capecitabine 500mg

Dosage Form:
Film-coated tablet

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Manufacturers:
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom

Dated this 14th day of April 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go2403



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 70


Gazette.govt.nz PDF NZ Gazette 2005, No 70





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Changed Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
14 April 2005
Medicines, Consent, Distribution, Concerta, Methylphenidate, Efexor-XR, Venlafaxine, Fragmin, Dalteparin, Pegasys, Peginterferon, Xeloda, Capecitabine
  • DON MATHESON, Deputy Director-General, Public Health